CASK (O14936) variants and mutations
CASK (also known as O14936) is a human protein-coding gene encoding a peripheral plasma membrane protein. It organizes synaptic and cell-junction protein complexes and also participates in transcriptional regulation during brain development. Loss-of-function variants can cause microcephaly with pontine and cerebellar hypoplasia, intellectual disability, epilepsy, and other X-linked neurodevelopmental phenotypes. This analysis covers 954 CASK variants and mutations. Of these, 63% have computational variant effect predictions. Disease context includes X-linked intellectual disability, Najm type, syndromic X-linked intellectual disability Najm type, and FG syndrome 4. Example CASK variants include M1L, M1V, and A2D.
Variant analysis overview
- Gene: CASK
- Protein: O14936
- UniProt accession: O14936
- Organism: Homo sapiens
- Variants analyzed: 954
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 778 unspecified-consequence records; 57 synonymous variants; 104 missense variants; 3 in-frame deletions; 5 stop-gained variants; 2 splice-region variants; 2 frameshift variants; 1 in-frame insertions; 2 substitution
- Prediction scores: 604 variants have prediction scores (63% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: X-linked intellectual disability, Najm type, syndromic X-linked intellectual disability Najm type, FG syndrome 4, cask-related x-linked intellectual disability, FG syndrome, hereditary disease, Intellectual disability, pontocerebellar hypoplasia, X-linked non-syndromic intellectual disability, developmental disability, X-linked syndromic intellectual disability, neurodevelopmental disorder.
Protein structure and variant hotspots
- Protein features: 6 domains; 2 binding sites; 8 post-translational modification sites.
- Structural context: 752 variants have structural context.
- PTM context: 9 variants overlap post-translational modification sites.
- Experimental data: 82 protein positions have experimental scores. Source: CASK PDZ domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable CASK variants
Examples include M1L, M1V, A2D, A2T, D3N, D5E, D5N, D5Y. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1L (p.Met1Leu), rs1556313516, ClinGen CA413002025, ClinVar RCV000579113, MetaLR 0.41, MetaSVM -0.16, Pathogenic, not provided
- M1V (p.Met1Val), rs1556313516, ClinGen CA413002027, ClinVar RCV002417108, ClinVar RCV003624490, MetaLR 0.41, MetaSVM -0.16, Pathogenic, Inborn genetic diseases
- A2D (p.Ala2Asp), cosmic curated COSV10810
- A2T (p.Ala2Thr), rs2520195945, ClinVar RCV004588882, Uncertain significance, not provided
- D3N (p.Asp3Asn), NCI-TCGA Cosmic COSV5936, cosmic curated COSV59363, Variant assessed as somatic; moderate impact.
- D5E (p.Asp5Glu), rs2148116158, ClinGen CA413001963, ClinVar RCV001927591, Ensembl rs2148116158, REVEL 0.16, CADD 19.80, Uncertain significance, Intellectual disability, CASK-related, X-linked
- D5N (p.Asp5Asn), cosmic curated COSV59374, Uncertain significance, Intellectual disability, CASK-related, X-linked
- D5Y (p.Asp5Tyr), NCI-TCGA Cosmic COSV5937, Variant assessed as somatic; moderate impact.
- V6A (p.Val6Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F8L (p.Phe8Leu), ExAC rs773495975, gnomAD rs773495975, REVEL 0.23, CADD 23.10
- E9* (p.Glu9Ter), cosmic curated COSV10810
- E9Q (p.Glu9Gln), cosmic curated COSV59377
- Y12* (p.Tyr12Ter), rs1021128001, ClinGen CA413001880, ClinVar RCV000999407, NCI-TCGA TCGA novel, Likely pathogenic
- E13* (p.Glu13Ter), rs769965673, ClinGen CA413001874, ClinVar RCV001268856, ExAC rs769965673, AlphaMissense 0.94, MetaLR 0.24, Pathogenic
- E13K (p.Glu13Lys), ExAC rs769965673, gnomAD rs769965673, REVEL 0.33, AlphaMissense 0.94, Pathogenic
- L14P (p.Leu14Pro), gnomAD rs1362387864, REVEL 0.58, CADD 29.50
- E16* (p.Glu16Ter), NCI-TCGA Cosmic COSV1005, Variant assessed as somatic; high impact.
- E16K (p.Glu16Lys), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10058, Variant assessed as somatic; moderate impact.
- G19E (p.Gly19Glu), rs2072812741, ClinGen CA413001800, NCI-TCGA Cosmic COSV5936, cosmic curated COSV59361, AlphaMissense 1.00, MetaLR 0.84, Uncertain significance, Syndromic X-linked intellectual disability Najm type
- G19R (p.Gly19Arg), rs727503840, ClinGen CA413001806, ClinVar RCV003040906, ClinVar RCV004765634, REVEL 0.82, CADD 32.00, Uncertain significance, not provided; Intellectual disability, CASK-related, X-linked
- G21D (p.Gly21Asp), rs2071299462, ClinGen CA413001061, ClinVar RCV001232847, ClinVar RCV004601416, AlphaMissense 1.00, MetaLR 0.97, Uncertain significance, Inborn genetic diseases; Intellectual disability, CASK-related, X-linked; not pr
- G21V (p.Gly21Val), rs2071299462, ClinGen CA413001060, ClinVar RCV003625588, AlphaMissense 1.00, MetaLR 0.97, Uncertain significance, Intellectual disability, CASK-related, X-linked
- F23S (p.Phe23Ser), cosmic curated COSV59368, REVEL 0.74, CADD 28.20
- V25A (p.Val25Ala), cosmic curated COSV59360
- R27* (p.Arg27Ter), rs794727270, ClinGen CA201623, cosmic curated COSV10882, ClinVar RCV000175755, Pathogenic
- R28* (p.Arg28Ter), rs587783370, ClinGen CA171494, ClinVar RCV000145415, ClinVar RCV000430705, CADD 35.00, Pathogenic, in FGS4
- R28L (p.Arg28Leu), rs137852816, ClinGen CA121531, ClinVar RCV000012288, UniProt VAR 058719, AlphaMissense 0.97, MetaLR 0.10, Pathogenic, in FGS4
- R28Q (p.Arg28Gln), NCI-TCGA Cosmic COSV5936, cosmic curated COSV59361, Variant assessed as somatic; moderate impact., in FGS4
- C29F (p.Cys29Phe), cosmic curated COSV59372
- C29Y (p.Cys29Tyr), NCI-TCGA Cosmic COSV5937, Variant assessed as somatic; moderate impact.
- I30V (p.Ile30Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N31S (p.Asn31Ser), rs2519892738, ClinGen CA413000948, ClinVar RCV002371511, ClinVar RCV003100138, REVEL 0.13, CADD 19.80, Uncertain significance, Inborn genetic diseases; not provided; Intellectual disability, CASK-related, X
- T34A (p.Thr34Ala), ExAC rs763309338, gnomAD rs763309338, REVEL 0.28, CADD 23.30
- T34I (p.Thr34Ile), NCI-TCGA Cosmic COSV5936, cosmic curated COSV59367, Variant assessed as somatic; moderate impact.
- G35E (p.Gly35Glu), rs1485547629, ClinGen CA413000898, ClinVar RCV001957049, TOPMed rs1485547629, AlphaMissense 0.68, MetaLR 0.33, Uncertain significance, Intellectual disability, CASK-related, X-linked
- Q37* (p.Gln37Ter), rs1556254569, ClinGen CA413000876, cosmic curated COSV59374, ClinVar RCV000620583, Pathogenic
- V40A (p.Val40Ala), gnomAD rs1241515079, REVEL 0.40, CADD 23.50
- V40I (p.Val40Ile), 1000Genomes rs749242018, ExAC rs749242018, gnomAD rs749242018, REVEL 0.15, CADD 22.20
- K41T (p.Lys41Thr), NCI-TCGA Cosmic COSV5936, cosmic curated COSV59363, Variant assessed as somatic; moderate impact.
- I42L (p.Ile42Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- I42S (p.Ile42Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V43I (p.Val43Ile), Ensembl rs2071298166
- D44G (p.Asp44Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F48L (p.Phe48Leu), cosmic curated COSV59364, REVEL 0.30, CADD 23.80
- S50* (p.Ser50Ter), cosmic curated COSV10462
- P52L (p.Pro52Leu), cosmic curated COSV10738
- P52S (p.Pro52Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G53R (p.Gly53Arg), Ensembl rs2071297675
- G53V (p.Gly53Val), cosmic curated COSV10058
- S55N (p.Ser55Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S55R (p.Ser55Arg), gnomAD rs1210711127, REVEL 0.49, CADD 25.50
- T56A (p.Thr56Ala), rs2519892374, ClinGen CA413000659, ClinVar RCV003625430, REVEL 0.30, CADD 20.60, Benign, Intellectual disability, CASK-related, X-linked
- T56I (p.Thr56Ile), cosmic curated COSV59361, REVEL 0.35, CADD 21.90
- D58N (p.Asp58Asn), Ensembl rs1231160273, REVEL 0.18, CADD 34.00
- L59=, rs1349847248, NCI-TCGA Cosmic COSV5936, Likely benign
- R61L (p.Arg61Leu), cosmic curated COSV59365, REVEL 0.58, CADD 23.70
- R61P (p.Arg61Pro), cosmic curated COSV59368
- R61Q (p.Arg61Gln), gnomAD rs1341763226, REVEL 0.38, CADD 26.40, Uncertain significance, Intellectual disability, CASK-related, X-linked
- R61W (p.Arg61Trp), rs2147833182, ClinGen CA413002739, cosmic curated COSV10810, ClinVar RCV001902667, REVEL 0.55, CADD 29.50, Uncertain significance, Intellectual disability, CASK-related, X-linked; not provided
- S64I (p.Ser64Ile), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10058, Variant assessed as somatic; moderate impact.
- S64N (p.Ser64Asn), rs1556121425, ClinGen CA413002718, ClinVar RCV000646770, Ensembl rs1556121425, REVEL 0.18, CADD 21.50, Uncertain significance, Intellectual disability, CASK-related, X-linked
- I65S (p.Ile65Ser), cosmic curated COSV10810
- P72L (p.Pro72Leu), ExAC rs747541503, gnomAD rs747541503, REVEL 0.57, CADD 26.70
- H73R (p.His73Arg), cosmic curated COSV10738
- L78F (p.Leu78Phe), cosmic curated COSV59365
- E79D (p.Glu79Asp), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10058, Variant assessed as somatic; moderate impact.
- E79V (p.Glu79Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S83* (p.Ser83Ter), NCI-TCGA Cosmic COSV5937, cosmic curated COSV59372, CADD 36.00, Variant assessed as somatic; high impact.
- L87I (p.Leu87Ile), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10058, REVEL 0.27, CADD 22.80, Variant assessed as somatic; moderate impact.
- Y88* (p.Tyr88Ter), NCI-TCGA TCGA novel, CADD 36.00, Variant assessed as somatic; high impact.
- V90A (p.Val90Ala), rs2147833052, ClinGen CA413002526, ClinVar RCV001867649, Ensembl rs2147833052, REVEL 0.39, CADD 25.50, Uncertain significance, Intellectual disability, CASK-related, X-linked
- F91L (p.Phe91Leu), NCI-TCGA Cosmic COSV5936, cosmic curated COSV59362, REVEL 0.32, CADD 23.80, Variant assessed as somatic; moderate impact.
- E92K (p.Glu92Lys), rs1310982151, ClinGen CA413002516, NCI-TCGA Cosmic COSV5936, cosmic curated COSV59363, REVEL 0.65, CADD 26.60, Uncertain significance, Intellectual disability, CASK-related, X-linked
- M94I (p.Met94Ile), rs2519520842, ClinGen CA413003134, ClinVar RCV003322090, REVEL 0.34, CADD 23.50, Uncertain significance, not provided
- M94T (p.Met94Thr), rs2147736309, ClinGen CA413003136, ClinVar RCV002221926, Ensembl rs2147736309, REVEL 0.59, CADD 25.30, Uncertain significance, not provided
- D95G (p.Asp95Gly), ExAC rs753922395, REVEL 0.35, CADD 32.00
- G96* (p.Gly96Ter), cosmic curated COSV59378
- G96V (p.Gly96Val), cosmic curated COSV59366, UniProt VAR 041956, REVEL 0.59, CADD 28.50, Uncertain significance, in a lung large cell carcinoma sample
- A97E (p.Ala97Glu), rs2068673777, ClinGen CA413003115, ClinVar RCV001267216, Ensembl rs2068673777, REVEL 0.34, CADD 22.50, Uncertain significance, Inborn genetic diseases
- A97V (p.Ala97Val), Ensembl rs2068673777, Uncertain significance
- E102G (p.Glu102Gly), rs1569429756, ClinGen CA413003079, cosmic curated COSV10058, ClinVar RCV000697924, REVEL 0.64, CADD 27.20, Pathogenic/Likely pathogenic, FG syndrome 4; Intellectual disability, CASK-related, X-linked
- E102Q (p.Glu102Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V104I (p.Val104Ile), ExAC rs761124811, gnomAD rs761124811, REVEL 0.21, CADD 23.60
- K105N (p.Lys105Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R106* (p.Arg106Ter), rs387906704, ClinGen CA250707, NCI-TCGA Cosmic COSV5937, cosmic curated COSV59376, CADD 35.00, Pathogenic
- R106Q (p.Arg106Gln), rs2147736164, ClinGen CA413003053, cosmic curated COSV59366, ClinVar RCV001907725, AlphaMissense 0.99, MetaLR 0.24, Uncertain significance, Intellectual disability, CASK-related, X-linked
- A107T (p.Ala107Thr), Ensembl rs1569429735
- D108H (p.Asp108His), cosmic curated COSV10462
- A109T (p.Ala109Thr), cosmic curated COSV59369, ExAC rs767887493, REVEL 0.27, CADD 22.30
- A109V (p.Ala109Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G110D (p.Gly110Asp), ExAC rs759852198, REVEL 0.63, CADD 25.00
- V112M (p.Val112Met), rs2147736091, ClinGen CA413003018, ClinVar RCV002026295, Ensembl rs2147736091, AlphaMissense 0.93, MetaLR 0.24, Uncertain significance, Intellectual disability, CASK-related, X-linked
- S114N (p.Ser114Asn), TOPMed rs1199090087, REVEL 0.39, CADD 25.20
- E115V (p.Glu115Val), rs886043662, ClinGen CA10605796, ClinVar RCV000347432, ClinVar RCV000543246, AlphaMissense 1.00, MetaLR 0.42, Uncertain significance, not provided; Intellectual disability, CASK-related, X-linked
- A118=, NCI-TCGA TCGA novel, Variant assessed as somatic; low impact.
- A118T (p.Ala118Thr), cosmic curated COSV10810
- S119R (p.Ser119Arg), rs2519495161, ClinGen CA413002950, ClinVar RCV003325171, REVEL 0.39, CADD 23.90, Uncertain significance, not provided
- H120R (p.His120Arg), rs1602550687, ClinGen CA413002944, ClinVar RCV001004663, Likely pathogenic, Syndromic X-linked intellectual disability Najm type
- M122E (p.Met122Glu), rs2519495064, ClinVar RCV004594845, Uncertain significance, FG syndrome 4
- M122I (p.Met122Ile), rs2519495023, ClinGen CA413002926, ClinVar RCV003513489, REVEL 0.26, CADD 22.70, Uncertain significance, Intellectual disability, CASK-related, X-linked
- M122L (p.Met122Leu), cosmic curated COSV59364
- R123K (p.Arg123Lys), NCI-TCGA Cosmic COSV5937, cosmic curated COSV59371, REVEL 0.28, CADD 23.20, Variant assessed as somatic; moderate impact.
- L126L (p.Leu126Leu), gnomAD X-41523023-C-A, CADD 21.20
- L126V (p.Leu126Val), rs2064660243, gnomAD X-41523025-G-C, CADD 22.80
- E127* (p.Glu127Ter), cosmic curated COSV10810, CADD 0.83
- A128T (p.Ala128Thr), cosmic curated COSV59376, CADD 1.98
- L129F (p.Leu129Phe), gnomAD X-41523002-C-G, CADD 20.40
- R130C (p.Arg130Cys), TOPMed rs1411378502, REVEL 0.40, CADD 29.20, Uncertain significance, not provided; Intellectual disability, CASK-related, X-linked
- R130H (p.Arg130His), NCI-TCGA Cosmic COSV5937, cosmic curated COSV59376, REVEL 0.21, CADD 26.00, Variant assessed as somatic; moderate impact.
- R130R (p.Arg130Arg), gnomAD X-41523008-T-C, CADD 18.70
- C132Y (p.Cys132Tyr), rs1247007000, gnomAD X-41523012-C-T, CADD 22.80
- H133R (p.His133Arg), cosmic curated COSV59370, REVEL 0.88, CADD 24.30
- R140G (p.Arg140Gly), rs2147718784, ClinGen CA413002801, ClinVar RCV001593357, Ensembl rs2147718784, REVEL 0.68, CADD 25.20, Uncertain significance, not provided
- D141H (p.Asp141His), rs2519494557, ClinGen CA413002793, ClinVar RCV003443865, REVEL 0.91, CADD 26.30, Uncertain significance, not provided
- V142M (p.Val142Met), rs2068557879, ClinGen CA413002786, ClinVar RCV003625557, Ensembl rs2068557879, REVEL 0.25, CADD 23.30, Uncertain significance, Intellectual disability, CASK-related, X-linked
- K143E (p.Lys143Glu), gnomAD X-41523019-T-C, CADD 21.70
- P144S (p.Pro144Ser), rs2147495797, ClinGen CA412999115, ClinVar RCV001879622, Ensembl rs2147495797, REVEL 0.77, CADD 32.00, Uncertain significance, Intellectual disability, CASK-related, X-linked
- H145R (p.His145Arg), rs2067197587, ClinGen CA412999107, ClinVar RCV001297652, Ensembl rs2067197587, REVEL 0.36, CADD 22.00, Uncertain significance, Intellectual disability, CASK-related, X-linked
- C146R (p.Cys146Arg), gnomAD rs1174393974, REVEL 0.70, CADD 27.10
- C146Y (p.Cys146Tyr), rs2067197487, ClinGen CA412999100, ClinVar RCV001572166, Ensembl rs2067197487, AlphaMissense 1.00, MetaLR 0.24, Pathogenic, not provided
- V147G (p.Val147Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L148I (p.Leu148Ile), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10058, REVEL 0.58, CADD 23.30, Variant assessed as somatic; moderate impact.
- A150S (p.Ala150Ser), ExAC rs748166255, gnomAD rs748166255
- A150T (p.Ala150Thr), ExAC rs748166255, gnomAD rs748166255, REVEL 0.38, CADD 26.70
- N154D (p.Asn154Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S155L (p.Ser155Leu), rs2519234687, cosmic curated COSV10810, ClinVar RCV004594906, REVEL 0.55, CADD 29.60, Likely pathogenic, FG syndrome 4
- P157L (p.Pro157Leu), cosmic curated COSV59377
- P157S (p.Pro157Ser), cosmic curated COSV59375, REVEL 0.50, CADD 25.70
- G161E (p.Gly161Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F163L (p.Phe163Leu), rs2147495667, ClinGen CA412998991, ClinVar RCV001526625, Ensembl rs2147495667, AlphaMissense 1.00, MetaLR 0.67, Likely pathogenic, Intellectual disability
- G164R (p.Gly164Arg), rs2067197219, ClinGen CA412998983, ClinVar RCV001260653, Ensembl rs2067197219, AlphaMissense 1.00, MetaLR 0.86, Likely pathogenic, Intellectual disability
- V165I (p.Val165Ile), rs1057521754, ClinGen CA412998978, ClinVar RCV001050347, Ensembl rs1057521754, REVEL 0.21, AlphaMissense 0.20, Likely benign, Intellectual disability, CASK-related, X-linked
- V165L (p.Val165Leu), rs1057521754, ClinGen CA16608929, ClinVar RCV000427392, Ensembl rs1057521754, AlphaMissense 0.20, MetaLR 0.16, Likely pathogenic, not provided
- A166D (p.Ala166Asp), rs2519234559, ClinGen CA412998970, ClinVar RCV003127303, REVEL 0.90, CADD 26.80, Pathogenic, Developmental disorder
- A166P (p.Ala166Pro), rs1556016347, ClinGen CA412998971, NCI-TCGA Cosmic COSV5937, cosmic curated COSV59372, AlphaMissense 1.00, MetaLR 0.71, Likely pathogenic, not provided
- L169* (p.Leu169Ter), rs2147495562, ClinGen CA412998948, ClinVar RCV002250990, Ensembl rs2147495562, CADD 31.00, Likely pathogenic
- G170A (p.Gly170Ala), rs2519234514, ClinGen CA412998941, ClinVar RCV003438127, Uncertain significance, not provided
- G170R (p.Gly170Arg), cosmic curated COSV59375, REVEL 0.36, CADD 22.10
- E171* (p.Glu171Ter), cosmic curated COSV59361
- G173A (p.Gly173Ala), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10058, Variant assessed as somatic; moderate impact.
- V175A (p.Val175Ala), rs781247892, ClinGen CA10390371, ClinVar RCV000483810, ClinVar RCV000685120, REVEL 0.35, CADD 22.30, Uncertain significance, Intellectual disability, CASK-related, X-linked; not provided; not specified
- A176G (p.Ala176Gly), NCI-TCGA Cosmic COSV5936, cosmic curated COSV59366, Variant assessed as somatic; moderate impact.
- A176P (p.Ala176Pro), Ensembl rs1025721036
- G177A (p.Gly177Ala), cosmic curated COSV10519
- G177V (p.Gly177Val), cosmic curated COSV59366
- R179C (p.Arg179Cys), cosmic curated COSV10519, NCI-TCGA TCGA novel, REVEL 0.62, CADD 31.00, Uncertain significance, Syndromic X-linked intellectual disability Najm type; not provided
- R179H (p.Arg179His), rs1336701127, ClinGen CA412998534, ClinVar RCV003624861, ClinVar RCV005931639, REVEL 0.46, CADD 27.60, Uncertain significance, Syndromic X-linked intellectual disability Najm type; FG syndrome 4; Intellectua
- V180D (p.Val180Asp), rs2519216387, ClinGen CA412998520, ClinVar RCV003992053, Uncertain significance, FG syndrome 4
- G181R (p.Gly181Arg), rs2519216366, ClinGen CA412998518, ClinVar RCV003625698, Uncertain significance, Intellectual disability, CASK-related, X-linked
- T182A (p.Thr182Ala), cosmic curated COSV10519
- T182P (p.Thr182Pro), rs1602431663, ClinGen CA915950943, ClinVar RCV001008315, Ensembl rs1602431663, Pathogenic
- H184N (p.His184Asn), rs2147479461, ClinGen CA412998484, ClinVar RCV001369476, Ensembl rs2147479461, REVEL 0.39, CADD 23.90, Uncertain significance, Intellectual disability, CASK-related, X-linked
- H184Y (p.His184Tyr), NCI-TCGA Cosmic COSV5936, cosmic curated COSV59363, Variant assessed as somatic; moderate impact.
- E189Q (p.Glu189Gln), rs2519216205, ClinGen CA412998412, ClinVar RCV002290204, Uncertain significance, Syndromic X-linked intellectual disability Najm type
- E189V (p.Glu189Val), cosmic curated COSV59364
- V191I (p.Val191Ile), TOPMed rs2067100760, Uncertain significance, not provided
- K192R (p.Lys192Arg), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10058, Variant assessed as somatic; moderate impact.
- R193I (p.Arg193Ile), rs1569379996, ClinGen CA412998355, ClinVar RCV000762626, Ensembl rs1569379996, AlphaMissense 0.99, MetaLR 0.21, Uncertain significance, not provided
- Y196* (p.Tyr196Ter), rs1008303488, ClinGen CA412998290, ClinVar RCV001725808, TOPMed rs1008303488, Pathogenic
- G197* (p.Gly197Ter), rs2067100386, ClinGen CA412998280, ClinVar RCV003147863, AlphaMissense 1.00, MetaLR 0.42, Pathogenic
- G197R (p.Gly197Arg), rs2067100386, ClinGen CA412998286, cosmic curated COSV59371, ClinVar RCV002016863, AlphaMissense 1.00, MetaLR 0.42, Uncertain significance, not provided; Intellectual disability, CASK-related, X-linked
- P199L (p.Pro199Leu), rs1569379968, ClinGen CA412998242, ClinVar RCV000686262, Ensembl rs1569379968, AlphaMissense 0.95, MetaLR 0.26, Uncertain significance, Intellectual disability, CASK-related, X-linked
- D201E (p.Asp201Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D201N (p.Asp201Asn), rs2519216043, ClinGen CA412998220, ClinVar RCV003511655, Uncertain significance, Intellectual disability, CASK-related, X-linked
- W203* (p.Trp203Ter), rs886039474, ClinGen CA10588785, cosmic curated COSV59362, ClinVar RCV000255294, Pathogenic
- W203C (p.Trp203Cys), cosmic curated COSV10058, REVEL 0.81, CADD 26.80
- W203G (p.Trp203Gly), ExAC rs773434345, gnomAD rs773434345
- G204A (p.Gly204Ala), TOPMed rs1313406532
- C205W (p.Cys205Trp), cosmic curated COSV59371
- G206D (p.Gly206Asp), rs587783367, ClinGen CA251022, ClinVar RCV000145409, Ensembl rs587783367, AlphaMissense 1.00, MetaLR 0.89, Conflicting interpretations, Syndromic X-linked intellectual disability Najm type
- G206S (p.Gly206Ser), rs2067099763, ClinGen CA412998108, NCI-TCGA Cosmic COSV5936, cosmic curated COSV59364, AlphaMissense 0.98, MetaLR 0.89, Conflicting interpretations, Intellectual disability; not provided; FG syndrome 4
- L209F (p.Leu209Phe), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10058, Variant assessed as somatic; moderate impact.
- L209P (p.Leu209Pro), rs1556014749, ClinGen CA412998045, ClinVar RCV000498072, ClinVar RCV000621770, AlphaMissense 1.00, MetaLR 0.56, Pathogenic/Likely pathogenic, not provided; Syndromic X-linked intellectual disability Najm type
- F210L (p.Phe210Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G215S (p.Gly215Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P218H (p.Pro218His), cosmic curated COSV10519
- F219C (p.Phe219Cys), gnomAD rs1189980578, REVEL 0.77, CADD 28.10, Uncertain significance
- F219S (p.Phe219Ser), rs1189980578, ClinGen CA412997843, ClinVar RCV001756782, gnomAD rs1189980578, REVEL 0.75, CADD 28.60, Uncertain significance, not provided
- Y220* (p.Tyr220Ter), rs747587301, ClinGen CA412997815, ClinVar RCV000497506, ExAC rs747587301, Pathogenic
- Y220C (p.Tyr220Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
Public CASK analysis runs
- CASK analysis run — CASK (954 variants) — completed 2026-08-19